アーユルヴェーダ市場
Ayurveda Market
アーユルヴェーダ市場調査レポート情報:製品別(医薬品、スキンケア製品、ヘアケア製品、ヘルスケア製品、オーラルケア製品、その他)、形態別(粉末、錠剤、カプセル、液体、その他)、用途別(ヘルスケア(呼... もっと見る
|
|
サマリー アーユルヴェーダ市場調査レポート情報:製品別(医薬品、スキンケア製品、ヘアケア製品、ヘルスケア製品、オーラルケア製品、その他)、形態別(粉末、錠剤、カプセル、液体、その他)、用途別(ヘルスケア(呼吸器系、消化器系、循環器系、感染症、整形外科系、その他)、パーソナルケア(オーラルケア、スキンケア(保湿剤、ローション、錠剤、カプセル、石鹸・ボディソープ、洗顔料、その他)、ヘアケア(ヘアシャンプー、ヘアマスク、錠剤・カプセル、ヘア美容液、ヘアコンディショナー、その他)、その他)、流通チャネル別(企業間取引(B2B)(卸売業者、薬局、スーパーマーケット、その他)、企業消費者間取引(B2C))、地域別(北米、欧州、アジア太平洋地域、その他の地域)2032年までの予測
市場概要
2023年のアーユルヴェーダ市場は145億6,756万米ドルと推定される。予測期間中、アーユルヴェーダ市場産業は16.13%の複合年間成長率(CAGR)を記録すると予測される。
アーユルヴェーダ市場は、アーユルヴェーダ製品に対する政府支援の増加、アーユルヴェーダに関連する健康・ウェルネス効果に対する意識の高まり、世界的なアーユルヴェーダ製品の採用拡大などにより成長を遂げている。
Dabur社の "Science in Action "とMaharishi Ayurveda社の#RightYourWrongsは、消費者が従来の医療に代わるホリスティックで自然な代替医療を求めるようになっている中、アーユルヴェーダの原理を広めるのに効果的である。このような取り組みは、一般消費者を啓蒙するだけでなく、若年層の共感を呼び、アーユルヴェーダ製品の魅力を高めている。アーユルヴェーダは、持続可能な治療法と予防医療に焦点を当てた需要の増加により、変化するヘルスケアの状況において重要な役割を担っている。
市場セグメント別インサイト
医薬品、スキンケア製品、ヘアケア製品、ヘルスケア製品、オーラルケア製品、その他がこのセグメントを構成している。
形態別では、粉末、錠剤、カプセル、液剤、その他で構成される。
このセグメントは2つのカテゴリーに分類される:ヘルスケア(呼吸器系、消化器系、循環器系、感染症、整形外科系、その他)とパーソナルケア(オーラルケア、スキンケア(保湿剤、ローション、錠剤、カプセル、石鹸・ボディソープ、洗顔料、その他)、ヘアケア(ヘアシャンプー、ヘアマスク、錠剤・カプセル、ヘアセラム、ヘアコンディショナー、その他))である。
また、流通チャネル別にB to B(卸売業者、薬局、スーパーマーケット、その他)とB to C(消費者向け)に分けられる。
地域別展望
世界のアーユルヴェーダ市場は以下の地域に分けられる:北米、欧州、アジア太平洋、中東・アフリカ、中南米である。アジア太平洋地域は、アーユルヴェーダに関連する健康・ウェルネス効果に対する意識の高まり、世界的なアーユルヴェーダ製品の採用拡大、アーユルヴェーダ製品に対する政府支援の増加などが主な要因である。消費者の嗜好は、インド、スリランカ、ネパールなどの国々で深く根付いているアーユルヴェーダの伝統に影響されており、その結果、国内外でのアーユルヴェーダ製品の普及が復活している。
天然製品やオーガニック製品に対する需要の高まり、業界再編、地理的拡大の必要性が、市場参加者間の合併・買収(M&A)活動の増加を促す主な要因となっている。例えば、2022年11月、インドの製薬会社であるMankind Pharmaは、アーユルヴェーダと薬用薬の生産、開発、販売を専門とするUpakarma Ayurveda Private Limitedを買収した。この買収の目的は、マンカインド・ファーマの広範な販売網を活用することで、ウパカルマ・アーユルヴェーダの製品とサービスの提供を拡大することである。
市場における主なプレーヤー
Emami Limited、Vicco Laboratories、Baidyanath、Hamdard Laboratories、Kerala Ayurveda Limited、Dabur Ltd.、Patanjali Ayurved Limited、Himalaya Wellness Company、Maharishi Ayurveda、Lotus Herbalsなどが市場の主要プレーヤーである。
ページTOPに戻る
目次 目次
2.
2.
2.
2.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
4.
4.
4.
4.
4.
4.
4.
4.
4.
4.
4.
4.
5.
5.
5.
5.
5.
5.
5.
5.
5.
5.
5.
6.
6.
6.
6.
6.
6.
6.
7.
7.
7.
7.
7.
7.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
8.
9.
9.
9.
9.
9.
9.
9.
9.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.3.5 スペイン ...............................................................................................................................................................................................................
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
11.
11.
11.
11.
11.
11.
11.
11.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.301
12.301
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
ページTOPに戻る
Summary Ayurveda Market Research Report Information by Product (Drugs, Skin Care Products, Hair Care Products, Health Care Products, Oral Care Products, and Others), by Form (Powder, Tablets, Capsules, Liquid and Others), by Application (Healthcare(Respiratory System, Gastrointestinal Care, Cardiovascular Health, Infectious Diseases, Orthopedic Health, Others) and Personal Care (Oral Care, Skin Care (Moisturizers, Lotions, Tablets, Capsules, Soaps & Bodywash, Facewash, Others), Hair Care(Hair Shampoo, Hair Masks, Tablets & Capsules, Hair Serums, Hair Conditioners, Others), Others)), by Distribution Channel (Business to Business (B2B) (Wholesalers, Pharmacies, Supermarkets, Others) and Business to Consumer (B2C)), and Region (North America, Europe, Asia-Pacific and Rest of the World) Forecast till 2032
Market Overview In 2023, the Ayurveda Market was estimated to be worth USD 14,567.56 million. During the forecast period, the Ayurveda Market industry is anticipated to experience a compound annual growth rate (CAGR) of 16.13%. The Ayurveda Market is experiencing growth due to the increasing government support for ayurveda products, the increasing awareness of the health and wellness benefits associated with ayurveda, and the growing adoption of ayurvedic products worldwide. Dabur's "Science in Action" and Maharishi Ayurveda's #RightYourWrongs are both effective in promoting Ayurvedic principles as consumers increasingly seek holistic and natural alternatives to conventional medicine. These initiatives not only educate the public but also resonate with younger audiences, thereby increasing the appeal of Ayurvedic products. Ayurveda is positioned as a critical actor in the changing healthcare landscape because of the increasing demand, which is driven by a focus on sustainable remedies and preventive health.
Market segment insights Drugs, skin care products, hair care products, health care products, oral care products, and others comprise this segment. Based on the form, this segment comprises Powder, Tablets, Capsules, Liquid, and Others. This segment is categorized into two categories: Healthcare (Respiratory System, Gastrointestinal Care, Cardiovascular Health, Infectious Diseases, Orthopedic Health, Others) and Personal Care (Oral Care, Skin Care (Moisturizers, Lotions, Tablets, Capsules, Soaps & Bodywash, Facewash, Others), Hair Care (Hair Shampoo, Hair Masks, Tablets & Capsules, Hair Serums, Hair Conditioners, Others). The segment is divided into Business to Business (B2B) (Wholesalers, Pharmacies, Supermarkets, Others) and Business to Consumer (B2C) based on the distribution channel. Regional Perspectives The global Ayurveda market is divided into the following regions: North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America. The Asia-Pacific market is primarily driven by the increasing awareness of the health and wellness benefits associated with ayurveda, as well as the growing adoption of ayurvedic products worldwide and the increasing government support for ayurveda products. Consumer preferences are being influenced by the deeply rooted traditions of Ayurveda in countries such as India, Sri Lanka, and Nepal, resulting in a resurgence in the prevalence of Ayurvedic products on both a local and international scale. The increasing demand for natural and organic products, industry consolidation, and the necessity to expand geographically are the primary factors driving the increase in merger and acquisition (M&A) activity among market participants. For example, in November 2022, Mankind Pharma, an Indian pharmaceutical company, acquired Upakarma Ayurveda Private Limited, a company that specializes in the production, development, and distribution of Ayurvedic and medicinal medications. The purpose of this acquisition is to expand Upakarma Ayurveda's product and service offerings by leveraging Mankind Pharma's extensive distribution network.
The primary players in the market
Emami Limited, Vicco Laboratories, Baidyanath, Hamdard Laboratories, Kerala Ayurveda Limited, Dabur Ltd., Patanjali Ayurved Limited, Himalaya Wellness Company, Maharishi Ayurveda, Lotus Herbals, and others are among the main players in the market.
ページTOPに戻る
Table of Contents TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ............................................................................................................... 29 2 MARKET INTRODUCTION ............................................................................................................ 31 2.1 DEFINITION ........................................................................................................................................................... 31 2.2 SCOPE OF THE STUDY ......................................................................................................................................... 31 2.3 RESEARCH OBJECTIVE ........................................................................................................................................ 31 2.4 MARKET STRUCTURE ......................................................................................................................................... 31 3 RESEARCH METHODOLOGY ...................................................................................................... 32 3.1 OVERVIEW ............................................................................................................................................................ 32 3.2 DATA FLOW .......................................................................................................................................................... 34 3.2.1 DATA MINING PROCESS ................................................................................................................................. 34 3.3 PURCHASED DATABASE: .................................................................................................................................... 35 3.4 SECONDARY SOURCES: ...................................................................................................................................... 36 3.4.1 SECONDARY RESEARCH DATA FLOW: ............................................................................................................. 37 3.5 PRIMARY RESEARCH: ......................................................................................................................................... 38 3.5.1 PRIMARY RESEARCH DATA FLOW: ................................................................................................................. 39 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: .......................................................................................... 40 3.6.1 REVENUE ANALYSIS APPROACH ..................................................................................................................... 40 3.7 DATA FORECASTING........................................................................................................................................... 41 3.7.1 DATA FORECASTING TYPE .............................................................................................................................. 41 3.8 DATA MODELING ................................................................................................................................................ 42 3.8.1 MICROECONOMIC FACTOR ANALYSIS: ............................................................................................................ 42 3.8.2 DATA MODELING: ........................................................................................................................................... 43 3.9 TEAMS AND ANALYST CONTRIBUTION ......................................................................................................... 45 4 MARKET DYNAMICS .................................................................................................................... 47 4.1 INTRODUCTION................................................ 47 4.2 DRIVERS.......................................................... 48 4.2.1 GROWING AWARENESS OF HEALTH AND WELLNESS BENEFITS ASSOCIATED WITH AYURVEDA ........................ 48 4.2.2 INCREASING GOVERNMENT SUPPORT FOR AYURVEDA PRODUCTS .................................................................. 48 4.2.3 GROWING ADOPTION FOR AYURVEDIC PRODUCTS ACROSS THE GLOBE ........................................................... 49 4.3 RESTRAINTS.............................................................. 50 4.3.1 STRICT SAFETY AND QUALITY STANDARDS .................................................................................................... 50 4.3.2 VOLUNTARY PRODUCT RECALL BY MARKET PLAYERS ..................................................................................... 51 4.4 OPPORTUNITY ..................................................................................................................................................... 53 4.4.1 GROWING GERIATRIC POPULATION ................................................................................................................ 53 4.4.2 INCREASING FUNDING AND INVESTMENT ASSOCIATED WITH AYURVEDA PRODUCTS ...................................... 53 4.4.3 INCREASING LAUNCH OF AYURVEDA PRODUCTS ON E-COMMERCE WEBSITES ................................................. 54 5 MARKET FACTOR ANALYSIS ...................................................................................................... 55 5.1 PORTER'S FIVE FORCES MODEL ....................................................................................................................... 55 5.1.1 THREAT OF NEW ENTRANTS ........................................................................................................................... 55 5.1.2 BARGAINING POWER OF SUPPLIERS ............................................................................................................... 56 5.1.3 THREAT OF SUBSTITUTES .............................................................................................................................. 56 5.1.4 BARGAINING POWER OF BUYERS .................................................................................................................... 56 5.1.5 INTENSITY OF RIVALRY .................................................................................................................................. 56 5.2 IMPACT OF COVID-19 ON GLOBAL AYURVEDA MARKET ......................................................................... 57 5.3 LIST OF MAJOR BRANDS ALONG WITH THEIR RANKING FOR HAIR CARE, BY REGION .................... 58 5.4 LIST OF MAJOR BRANDS ALONG WITH THEIR RANKING FOR SKINCARE, BY REGION ...................... 63 5.5 QUALITATIVE ANALYSIS ON BRAND POSITIONING FOR HAIR CARE ALONG WITH COMPETITIVE DASHBOARD ANALYSIS OF BRAND............ 68 5.6 QUALITATIVE ON BRAND POSITIONING FOR SKIN CARE ALONG WITH COMPETITIVE DASHBOARD ANALYSIS OF BRAND.................................................. 70 6 GLOBAL AYURVEDA MARKET, BY PRODUCT ........................................................................... 81 6.1 OVERVIEW ............................................................................................................................................................ 81 6.2 DRUGS .................................................................................................................................................................... 83 6.3 SKIN CARE PRODUCTS ........................................................................................................................................ 84 6.4 HAIR CARE PRODUCTS ....................................................................................................................................... 84 6.5 HEALTH CARE PRODUCTS ................................................................................................................................. 85 6.6 ORAL CARE PRODUCTS ...................................................................................................................................... 85 6.7 OTHERS .................................................................................................................................................................. 86 7 GLOBAL AYURVEDA MARKET, BY FORM .................................................................................. 87 7.1 OVERVIEW ............................................................................................................................................................ 87 7.2 POWDER ................................................................................................................................................................ 89 7.3 TABLETS ................................................................................................................................................................. 90 7.4 CAPSULES .............................................................................................................................................................. 90 7.5 LIQUID.................................................................................................................................................................... 90 7.6 OTHERS .................................................................................................................................................................. 91 8 GLOBAL AYURVEDA MARKET, BY APPLICATION ..................................................................... 92 8.1 OVERVIEW................................................................................. 92 8.2 HEALTHCARE........................................................................ 95 8.2.1 RESPIRATORY SYSTEM...................................................... 95 8.2.2 GASTROINTESTINAL CARE....................................................... 96 8.2.3 CARDIOVASCULAR HEALTH................................................ 96 8.2.4 INFECTIOUS DISEASES...................................................... 97 8.2.5 ORTHOPEDIC HEALTH .................................................................................................................................... 97 8.2.6 OTHERS ......................................................................................................................................................... 97 8.3 PERSONAL CARE .................................................................................................................................................. 98 8.3.1 ORAL CARE .................................................................................................................................................... 99 8.3.2 SKIN CARE...................................................... 99 8.3.2.1 MOISTURIZERS........................................................... 100 8.3.2.1.1 WHOLESALERS.......................................................... 101 8.3.2.1.2 DIRECT TO CONSUMERS....................................... 101 8.3.2.1.3 OTHERS............................................................ 102 8.3.2.2 LOTIONS............................................................. 102 8.3.2.2.1 WHOLESALERS.............................................. 103 8.3.2.2.2 DIRECT TO CONSUMERS............................... 103 8.3.2.2.3 OTHERS............................................................ 103 8.3.2.3 TABLETS............................................................... 104 8.3.2.3.1 WHOLESALERS..................................................... 104 8.3.2.3.2 DIRECT TO CONSUMERS............................................. 105 8.3.2.3.3 OTHERS...................................................... 105 8.3.2.4 CAPSULES...................................................................... 106 8.3.2.4.1 WHOLESALERS ................................................................................................................................. 106 8.3.2.4.2 DIRECT TO CONSUMERS........................................... 106 8.3.2.4.3 OTHERS................................................................ 107 8.3.2.5 SOAPS & BODYWASH ............................................................................................................................. 107 8.3.2.5.1 WHOLESALERS ................................................................................................................................. 108 8.3.2.5.2 DIRECT TO CONSUMERS.......................................... 108 8.3.2.5.3 OTHERS....................................................................... 109 8.3.2.6 FACEWASH......................................................................... 109 8.3.2.6.1 WHOLESALERS.............................................................. 110 8.3.2.6.2 DIRECT TO CONSUMERS.............................................. 110 8.3.2.6.3 OTHERS..................................................................... 111 8.3.2.7 OTHERS................................................................ 111 8.3.2.7.1 WHOLESALERS........................................................... 112 8.3.2.7.2 DIRECT TO CONSUMERS................................... 112 8.3.2.7.3 OTHERS.......................................................... 113 8.3.3 HAIR CARE ..................................................................................................................................................... 114 8.3.3.1 HAIR SHAMPOO ..................................................................................................................................... 115 8.3.3.1.1 WHOLESALERS ................................................................................................................................. 115 8.3.3.1.2 DIRECT TO CONSUMERS ................................................................................................................... 115 8.3.3.1.3 OTHERS................................................................... 116 8.3.3.2 HAIR MASKS.................................................... 116 8.3.3.2.1 WHOLESALERS........................................................ 117 8.3.3.2.2 DIRECT TO CONSUMERS....................................... 117 8.3.3.2.3 OTHERS............................................................................ 117 8.3.3.3 TABLETS & CAPSULES ............................................................................................................................ 118 8.3.3.3.1 WHOLESALERS...................................................... 119 8.3.3.3.2 DIRECT TO CONSUMERS........................................ 119 8.3.3.3.3 OTHERS......................................................... 119 8.3.3.4 HAIR SERUMS........................................................... 120 8.3.3.4.1 WHOLESALERS......................................................... 121 8.3.3.4.2 DIRECT TO CONSUMERS......................................... 121 8.3.3.4.3 OTHERS....................................................... 122 8.3.3.5 HAIR CONDITIONERS......................................................... 122 8.3.3.5.1 WHOLESALERS ................................................................................................................................. 123 8.3.3.5.2 DIRECT TO CONSUMERS ................................................................................................................... 123 8.3.3.5.3 OTHERS............................................................. 124 8.3.3.6 OTHERS.................................................................. 124 8.3.3.6.1 WHOLESALERS........................................... 125 8.3.3.6.2 DIRECT TO CONSUMERS................................ 125 8.3.3.6.3 OTHERS............................................................... 126 8.3.4 OTHERS........................................................................... 126 9 GLOBAL AYURVEDA MARKET, BY DISTRIBUTION CHANNEL .................................................. 127 9.1 OVERVIEW ............................................................................................................................................................ 127 9.2 SUPERMARKETS ................................................................................................................................................... 130 9.3 PHARMACIES ........................................................................................................................................................ 131 9.4 DEPARTMENTAL STORES ................................................................................................................................... 131 9.5 BEAUTY SPA/SALON ............................................................................................................................................ 132 9.6 WHOLESALERS ..................................................................................................................................................... 132 9.7 DIRECT TO CONSUMERS .................................................................................................................................... 133 9.8 OTHERS .................................................................................................................................................................. 133 10 GLOBAL AYURVEDA MARKET, BY REGION ............................................................................... 134 10.1 OVERVIEW ............................................................................................................................................................ 134 10.2 NORTH AMERICA ................................................................................................................................................ 135 10.2.1 US.................................................................................................................................................................. 144 10.2.2 CANADA ........................................................................................................................................................ 151 10.3 EUROPE .................................................................................................................................................................. 159 10.3.1 GERMANY ...................................................................................................................................................... 168 10.3.2 FRANCE ......................................................................................................................................................... 175 10.3.3 UK ................................................................................................................................................................. 182 10.3.4 ITALY ............................................................................................................................................................. 189 10.3.5 SPAIN ............................................................................................................................................................ 196 10.3.6 REST OF EUROPE ............................................................................................................................................ 202 10.4 ASIA PACIFIC ........................................................................................................................................................ 210 10.4.1 CHINA ............................................................................................................................................................ 219 10.4.2 INDIA ............................................................................................................................................................. 226 10.4.3 JAPAN ........................................................................................................................................................... 233 10.4.4 AUSTRALIA .................................................................................................................................................... 240 10.4.5 SOUTH KOREA ................................................................................................................................................ 247 10.4.6 REST OF ASIA PACIFIC.................................................................................................................................... 254 10.5 REST OF THE WORLD ......................................................................................................................................... 262 10.5.1 MIDDLE EAST & AFRICA .................................................................................................................................. 271 10.5.2 SOUTH AMERICA ............................................................................................................................................ 278 11 COMPETITIVE LANDSCAPE ........................................................................................................ 287 11.1 INTRODUCTION ................................................................................................................................................... 287 11.2 MARKET SHARE ANALYSIS, 2023 ...................................................................................................................... 287 11.3 COMPETITOR DASHBOARD .............................................................................................................................. 288 11.4 PUBLIC PLAYERS STOCK SUMMARY ............................................................................................................... 289 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL ............................................................................... 289 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ........................................................................................... 289 11.6.1 PRODUCT LAUNCH/PRODUCT EXPANSION ...................................................................................................... 289 11.6.2 EXPANSION.............................................................................. 291 12 COMPANY PROFILES .................................................................................................................. 292 12.1 EMAMI LIMITED .................................................................................................................................................. 292 12.1.1 COMPANY OVERVIEW ..................................................................................................................................... 292 12.1.2 FINANCIAL OVERVIEW .................................................................................................................................... 293 12.1.3 PRODUCTS OFFERED ...................................................................................................................................... 294 12.1.4 KEY DEVELOPMENTS ...................................................................................................................................... 294 12.1.5 SWOT ANALYSIS ............................................................................................................................................ 294 12.1.6 KEY STRATEGIES ............................................................................................................................................ 295 12.2 VICCO LABORATORIES ...................................................................................................................................... 296 12.2.1 COMPANY OVERVIEW ..................................................................................................................................... 296 12.2.2 FINANCIAL OVERVIEW .................................................................................................................................... 296 12.2.3 PRODUCTS OFFERED ...................................................................................................................................... 296 12.2.4 KEY DEVELOPMENTS ...................................................................................................................................... 297 12.2.5 KEY STRATEGIES ............................................................................................................................................ 297 12.3 BAIDYANATH...................................................................... 298 12.3.1 COMPANY OVERVIEW.................................................... 298 12.3.2 FINANCIAL OVERVIEW...................................................... 298 12.3.3 PRODUCTS OFFERED............................................................ 298 12.3.4 KEY DEVELOPMENTS............................................................. 300 12.3.5 KEY STRATEGIES.......................................................... 300 12.4 HAMDARD LABORATORIES......................................... 301 12.4.1 COMPANY OVERVIEW................................................... 301 12.4.2 FINANCIAL OVERVIEW................................................... 301 12.4.3 PRODUCTS OFFERED................................................ 302 12.4.4 KEY DEVELOPMENTS.......................................................... 303 12.4.5 KEY STRATEGIES............................................................ 304 12.5 KERALA AYURVEDA LIMITED............................................. 305 12.5.1 COMPANY OVERVIEW.......................................................... 305 12.5.2 FINANCIAL OVERVIEW...................................................... 305 12.5.3 PRODUCTS OFFERED....................................................................... 306 12.5.4 KEY DEVELOPMENTS................................................. 306 12.5.5 SWOT ANALYSIS................................................ 307 12.5.6 KEY STRATEGIES............................................................ 307 12.6 DABUR LTD......................................................................... 308 12.6.1 COMPANY OVERVIEW.................................................... 308 12.6.2 FINANCIAL OVERVIEW.......................................................... 308 12.6.3 PRODUCT OFFERED.......................................................... 310 12.6.4 KEY DEVELOPMENTS................................................... 312 12.6.5 SWOT ANALYSIS............................................................... 313 12.6.6 KEY STRATEGIES................................................... 313 12.7 PATANJALI AYURVED LIMITED................................................. 314 12.7.1 COMPANY OVERVIEW................................................................... 314 12.7.2 FINANCIAL OVERVIEW............................................................... 315 12.7.3 PRODUCTS OFFERED.................................................................. 316 12.7.4 KEY DEVELOPMENTS......................................................... 317 12.7.5 SWOT ANALYSIS...................................................................... 317 12.7.6 KEY STRATEGIES......................................................... 318 12.8 HIMALAYA WELLNESS COMPANY................................ 319 12.8.1 COMPANY OVERVIEW..................................................... 319 12.8.2 FINANCIAL OVERVIEW.......................................................... 319 12.8.3 PRODUCT OFFERED.............................................................. 320 12.8.4 KEY DEVELOPMENTS.................................................. 322 12.8.5 SWOT ANALYSIS........................................................................................... 323 12.8.6 KEY STRATEGIES................................................................ 323 12.9 MAHARISHI AYURVEDA...................................................... 324 12.9.1 COMPANY OVERVIEW......................................................... 324 12.9.2 FINANCIAL OVERVIEW.............................................. 324 12.9.3 PRODUCT OFFERED ........................................................................................................................................ 324 12.9.4 KEY DEVELOPMENTS ...................................................................................................................................... 326 12.9.5 KEY STRATEGIES ............................................................................................................................................ 326 12.10 LOTUS HERBALS ................................................................................................................................................... 327 12.10.1 COMPANY OVERVIEW ..................................................................................................................................... 327 12.10.2 FINANCIAL OVERVIEW .................................................................................................................................... 327 12.10.3 PRODUCT OFFERED ........................................................................................................................................ 327 12.10.4 KEY DEVELOPMENTS ...................................................................................................................................... 328 12.10.5 KEY STRATEGIES ............................................................................................................................................ 329 13 DATA CITATIONS ......................................................................................................................... 330
ページTOPに戻る
Market Research Future社の 医療分野 での最新刊レポート
-
抗肥満薬市場調査レポート:治療タイプ別(セロトニン・ノルエピネフリン再取り込み阻害薬、選択的セロトニン2C受容体作動薬、ノルエピネフリン・ドパミン再取り込み阻害薬)、リパーゼ阻害薬、GLP-1受容体作動薬、併用薬、その他)、薬物タイプ別(処方薬、市販薬)、作用機序別(中枢性抗肥満薬、末梢性抗肥満薬)、投与経路別(経口、皮下)、流通チャネル別(病院薬局、小売薬局、オンライン薬局)、地域別(北米、欧州、アジア太平洋、南米、中東、アフリカ) 2035年までの予測
-
ジェネリック医薬品市場調査レポート:適応症別(中枢神経系(CNS)、循環器、泌尿器、腫瘍、呼吸器、その他)、投与経路別(経口、局所、非経口、その他)、流通チャネル別(病院薬局、小売薬局、オンライン薬局)、地域別(北米、欧州、アジア太平洋地域、その他の地域) 2035年までの予測
-
多発性硬化症治療装置市場調査レポート:タイプ別[原発性進行性多発性硬化症(PPMS)、二次性進行性多発性硬化症(SPMS)、再発寛解型多発性硬化症(RRMS)、臨床的孤立症候群(CIS)]、治療装置別[電気刺激装置(機能的電気刺激(FES)、経皮的電気神経刺激(TENS), 神経刺激装置(脊髄刺激(SCS), 脳深部刺激(DBS))]、エンドユーザー別(病院&クリニック, 外来手術センター)、地域別(北米, 欧州, アジア太平洋, 南米, 中東およびアフリカ)2032年までの予測
-
Peptide Cosmetic API Research Report by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Forecast till 2035
-
Ischemic Stroke Surgery Market Research Report by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, Others), by Product Type (Catheters, Aspiration System, Guidewire, Microcatheter, Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035
-
アフリカの動物用医薬品市場レポート 動物種別(動物、コンパニオンアニマル)、製品別(医薬品、ワクチン、飼料添加物、衛生用品、診断薬)、流通チャネル別(小売薬局、Eコマース、その他)、地域別(エジプト、ナイジェリア、アルジェリア、チュニジア、リビア、ウガンダ、タンザニア、南スーダン、ケニア、エチオピア、アフリカのその他)の調査レポート情報 2032年までの予測
-
アルテスネート注射剤の世界市場調査レポート:純度別(アルテスネート0.99、アルテスネート0.98)、用途別(マラリア、重症マラリア、脳マラリア、合併症のないマラリア、その他の用途)、エンドユーザー別(病院、診療所、薬局、政府機関、非政府組織)、流通チャネル別(直販、流通業者および卸売業者、小売薬局、オンライン販売)、地域別(北米、欧州、APAC、南米、MEA)2032年までの予測
-
欧州液体クロマトグラフィー機器サービス市場2030年までの予測調査レポート
-
アジア太平洋地域の血液病理学用バイオマーカー市場調査レポート情報:タイプ別(製品・サービス)、癌タイプ別(リンパ腫、白血病)、技術カテゴリー別(NGS、PCR、IHC、FISH、その他)、2032年までの地域別予測
-
骨接合インプラント市場調査レポート情報:製品別(スクリューとプレート、ワイヤーとピン、髄内ロッドとネイル、脊椎固定装置)、材料別(ステンレス鋼、チタンとチタン合金、生体吸収性ポリマー、その他)、骨折タイプ別(股関節骨折、膝関節骨折、脊椎骨折、肩関節骨折、その他)、エンドユーザー別(病院、整形外科クリニック、外来手術センター)、地域別(北米、欧州、アジア太平洋、その他地域) 2032年までの予測
本レポートと同じKEY WORD()の最新刊レポート
- 本レポートと同じKEY WORDの最新刊レポートはありません。
よくあるご質問
Market Research Future社はどのような調査会社ですか?
マーケットリサーチフューチャー(Market Research Future)は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。
下記分野については、分野毎に専... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|